238 / 1138
•
US National Cancer Database
•
Propensity-matched analysis of
1502 patients
, 50% of whom
received SBRT and others conventional radiotherapy
•
3-year overall survival
in matched cohort was
40% versus
48%
for conventional radiotherapy vs SABR (p = 0.001)
•
Hazard ratio for SABR from a univariate Cox regression was
0.82
(95% CI:
0.73–0.92
, p = 0.001)
Koshy M, Radioth Oncol 2015
CER of conventional radiotherapy vs SABR